Illumina Inc (ILMN)

$101.80 +2.51 (2.53%)
Market Cap 15.26B
Revenue (ttm) 4.37B
Net Income (ttm) -1.22B
EPS (ttm) N/A
PE Ratio 24.23
Forward PE 22.38
Profit Margin -27.97%
Debt to Equity Ratio 0.66
Volume 1,965,300
Avg Vol 2,168,644
Day's Range N/A - N/A
Shares Out 153.70M
Stochastic %K 80%
Beta 1.37
Analysts Sell
Price Target $109.91

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4545
Address:
5200 Illumina Way, San Diego, United States
tarzzanman
tarzzanman Aug. 19 at 8:09 PM
$CAKE $ILMN $NVO $LVMH Holding well very in this bearish scenario 👍🏻
0 · Reply
mstan
mstan Aug. 16 at 5:26 PM
$ILMN
0 · Reply
IN0V8
IN0V8 Aug. 4 at 3:35 PM
$ILMN Stephens raises target price to $110 from $105
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 2:43 PM
Morgan Stanley has updated their rating for Illumina ( $ILMN ) to Equal-Weight with a price target of 105.
0 · Reply
Boomrang
Boomrang Aug. 4 at 7:07 AM
$ILMN upgraded by Morgan Stanley by $10
0 · Reply
arielkhanMD
arielkhanMD Aug. 3 at 8:27 AM
$PACB $ILMN $ARKG $ARKK one thing you have to understand is that illumina is the best thermostat for the industry/market appetite for sequencing technology. And they had a great ER even with having been barred from selling new sequencers and having limited operations in China. That says a lot. Many in the industry think that there’s a lot of competition from illumina and other sequencing companies. However, the industry is growing so fast that I don’t think this has a much of an impact on pacbio. I’m actually really excited for this ER more so than any. I think VEGA demand will outpace supply into Q3. This one peace of news will really change the value of the company. I hope we really get some clarity on this w this upcoming ER. also really curious about the consumable revenue
0 · Reply
poopnugs
poopnugs Aug. 2 at 2:00 PM
$PACB i wonder if some of the drop (besides general market weakness) had to do with $ILMN earnings. perhaps investors were unimpressed and extrapolated to $PACB
1 · Reply
mstan
mstan Aug. 2 at 6:12 AM
$ILMN they move the stock and then raise the PT to that price after pull back🤔 .OK they own it, with almost 100% ownership . It looks like tweezer top on weekly probably going to correction with the rest of the market. But if you for LT don't pay attention, most likely the bottom is in, some smoke and mirror along the way as usual.
0 · Reply
Joy_Kitten
Joy_Kitten Aug. 1 at 7:17 PM
$ILMN why would this fall?
0 · Reply
IN0V8
IN0V8 Aug. 1 at 6:32 PM
$ILMN Barclays raises target price to $90 from $85 BofA Global Research raises price objective to $75 from $70 Canaccord Genuity raises target price to $105 from $99 J.P.Morgan raises target price to $100.00 from $85.00 Jefferies raises target price to $100 from $90 TD Cowen raises target price to $110 from $106 UBS raises target price to $110 from $98
0 · Reply
Latest News on ILMN
Illumina: The Stock Is Still Undervalued

Aug 4, 2025, 4:23 AM EDT - 19 days ago

Illumina: The Stock Is Still Undervalued

These Analysts Boost Their Forecasts On Illumina Following Upbeat Results

Aug 1, 2025, 12:02 PM EDT - 22 days ago

These Analysts Boost Their Forecasts On Illumina Following Upbeat Results

Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 1:25 AM EDT - 22 days ago

Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025

Jul 31, 2025, 4:05 PM EDT - 22 days ago

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025

Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling

Jul 30, 2025, 9:15 AM EDT - 24 days ago

Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling

Illumina Stock: What Went Wrong And Why It's Best To Stay Away

Jul 17, 2025, 7:45 AM EDT - 5 weeks ago

Illumina Stock: What Went Wrong And Why It's Best To Stay Away

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds

Jul 12, 2025, 3:46 AM EDT - 6 weeks ago

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Jul 10, 2025, 4:05 PM EDT - 6 weeks ago

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year

Jul 10, 2025, 9:15 AM EDT - 6 weeks ago

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

Jun 23, 2025, 7:13 AM EDT - 2 months ago

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

LAB

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

Jun 18, 2025, 9:00 AM EDT - 2 months ago

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Jun 10, 2025, 4:01 PM EDT - 2 months ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

May 29, 2025, 2:01 PM EDT - 3 months ago

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

May 29, 2025, 12:18 AM EDT - 3 months ago

Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

May 28, 2025, 12:22 PM EDT - 3 months ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD IBB NVS SDGR

Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

May 28, 2025, 9:15 AM EDT - 3 months ago

Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry's Largest NGS-Based Proteomics Panel

May 19, 2025, 11:47 AM EDT - 3 months ago

Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry's Largest NGS-Based Proteomics Panel

Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%

May 16, 2025, 11:28 AM EDT - 3 months ago

Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%

JBLU

Illumina To Webcast Upcoming Investor Conference

May 14, 2025, 4:05 PM EDT - 3 months ago

Illumina To Webcast Upcoming Investor Conference

Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications

May 13, 2025, 9:15 AM EDT - 3 months ago

Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications

Illumina Analysts Lower Their Forecasts After Q1 Results

May 12, 2025, 11:28 AM EDT - 3 months ago

Illumina Analysts Lower Their Forecasts After Q1 Results

Illumina: Multiple Headwinds Point To Limited Upside In 2025

May 10, 2025, 10:58 PM EDT - 3 months ago

Illumina: Multiple Headwinds Point To Limited Upside In 2025

Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:01 PM EDT - 3 months ago

Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript

Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development

May 1, 2025, 9:15 AM EDT - 4 months ago

Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development

Target Validation for Genetic Targets Innovation Research Report 2025: 14,172 Deals Totaling $11.4 Billion - BGI biotech and illumina are Among the Leaders with Strong Portfolios

Apr 18, 2025, 10:25 AM EDT - 4 months ago

Target Validation for Genetic Targets Innovation Research Report 2025: 14,172 Deals Totaling $11.4 Billion - BGI biotech and illumina are Among the Leaders with Strong Portfolios

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

Apr 15, 2025, 9:15 AM EDT - 4 months ago

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

TEM

Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025

Apr 10, 2025, 4:05 PM EDT - 4 months ago

Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025

Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholders

Mar 29, 2025, 7:25 AM EDT - 5 months ago

Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholders

Is Illumina Undervalued After An 83% Drop In Its Stock Price?

Mar 27, 2025, 8:35 AM EDT - 5 months ago

Is Illumina Undervalued After An 83% Drop In Its Stock Price?

Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors

Mar 25, 2025, 9:00 AM EDT - 5 months ago

Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors

Activist investor Keith Meister to join Illumina's board, WSJ reports

Mar 25, 2025, 8:18 AM EDT - 5 months ago

Activist investor Keith Meister to join Illumina's board, WSJ reports

Activist Investor Meister to Join Illumina's Board

Mar 25, 2025, 8:00 AM EDT - 5 months ago

Activist Investor Meister to Join Illumina's Board

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

Mar 19, 2025, 9:15 AM EDT - 5 months ago

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

Illumina lowers outlook due to China sales ban, to cut $100 million in costs

Mar 10, 2025, 4:22 PM EDT - 5 months ago

Illumina lowers outlook due to China sales ban, to cut $100 million in costs

Illumina addresses recent developments in China

Mar 10, 2025, 4:10 PM EDT - 5 months ago

Illumina addresses recent developments in China

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban

Mar 10, 2025, 4:01 PM EDT - 5 months ago

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban

Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year

Mar 6, 2025, 9:15 AM EST - 6 months ago

Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year

US Firm Illumina Faces Setback as China Blocks Imports Amid Escalating Trade War

Mar 4, 2025, 9:57 AM EST - 6 months ago

US Firm Illumina Faces Setback as China Blocks Imports Amid Escalating Trade War

Illumina Stock Drops as China Bans Imports of Gene-Sequencing Technology

Mar 4, 2025, 9:38 AM EST - 6 months ago

Illumina Stock Drops as China Bans Imports of Gene-Sequencing Technology

China bans imports of Illumina's gene sequencers

Mar 4, 2025, 12:57 AM EST - 6 months ago

China bans imports of Illumina's gene sequencers

Illumina, Inc. (ILMN) AGBT Investor Session Conference (Transcript)

Feb 25, 2025, 7:43 PM EST - 6 months ago

Illumina, Inc. (ILMN) AGBT Investor Session Conference (Transcript)

Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology

Feb 24, 2025, 9:15 AM EST - 6 months ago

Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology

Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions

Feb 21, 2025, 9:15 AM EST - 6 months ago

Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions

Illumina unveils first-of-its-kind spatial transcriptomics technology

Feb 19, 2025, 9:15 AM EST - 6 months ago

Illumina unveils first-of-its-kind spatial transcriptomics technology

Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference

Feb 18, 2025, 4:05 PM EST - 6 months ago

Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference

Trump's Cuts to Medical Research Are Hurting These Stocks

Feb 12, 2025, 7:19 PM EST - 6 months ago

Trump's Cuts to Medical Research Are Hurting These Stocks

PACB TXG

Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability

Feb 10, 2025, 7:17 AM EST - 6 months ago

Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability

Illumina Analysts Slash Their Forecasts Following Q4 Results

Feb 7, 2025, 2:22 PM EST - 7 months ago

Illumina Analysts Slash Their Forecasts Following Q4 Results

Illumina, Inc. (ILMN) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 9:33 PM EST - 7 months ago

Illumina, Inc. (ILMN) Q4 2024 Earnings Call Transcript

Illumina forecasts 2025 revenue largely below estimates

Feb 6, 2025, 4:42 PM EST - 7 months ago

Illumina forecasts 2025 revenue largely below estimates

tarzzanman
tarzzanman Aug. 19 at 8:09 PM
$CAKE $ILMN $NVO $LVMH Holding well very in this bearish scenario 👍🏻
0 · Reply
mstan
mstan Aug. 16 at 5:26 PM
$ILMN
0 · Reply
IN0V8
IN0V8 Aug. 4 at 3:35 PM
$ILMN Stephens raises target price to $110 from $105
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 2:43 PM
Morgan Stanley has updated their rating for Illumina ( $ILMN ) to Equal-Weight with a price target of 105.
0 · Reply
Boomrang
Boomrang Aug. 4 at 7:07 AM
$ILMN upgraded by Morgan Stanley by $10
0 · Reply
arielkhanMD
arielkhanMD Aug. 3 at 8:27 AM
$PACB $ILMN $ARKG $ARKK one thing you have to understand is that illumina is the best thermostat for the industry/market appetite for sequencing technology. And they had a great ER even with having been barred from selling new sequencers and having limited operations in China. That says a lot. Many in the industry think that there’s a lot of competition from illumina and other sequencing companies. However, the industry is growing so fast that I don’t think this has a much of an impact on pacbio. I’m actually really excited for this ER more so than any. I think VEGA demand will outpace supply into Q3. This one peace of news will really change the value of the company. I hope we really get some clarity on this w this upcoming ER. also really curious about the consumable revenue
0 · Reply
poopnugs
poopnugs Aug. 2 at 2:00 PM
$PACB i wonder if some of the drop (besides general market weakness) had to do with $ILMN earnings. perhaps investors were unimpressed and extrapolated to $PACB
1 · Reply
mstan
mstan Aug. 2 at 6:12 AM
$ILMN they move the stock and then raise the PT to that price after pull back🤔 .OK they own it, with almost 100% ownership . It looks like tweezer top on weekly probably going to correction with the rest of the market. But if you for LT don't pay attention, most likely the bottom is in, some smoke and mirror along the way as usual.
0 · Reply
Joy_Kitten
Joy_Kitten Aug. 1 at 7:17 PM
$ILMN why would this fall?
0 · Reply
IN0V8
IN0V8 Aug. 1 at 6:32 PM
$ILMN Barclays raises target price to $90 from $85 BofA Global Research raises price objective to $75 from $70 Canaccord Genuity raises target price to $105 from $99 J.P.Morgan raises target price to $100.00 from $85.00 Jefferies raises target price to $100 from $90 TD Cowen raises target price to $110 from $106 UBS raises target price to $110 from $98
0 · Reply
v92
v92 Aug. 1 at 6:17 PM
$ILMN What a trash stock. Even after raising their prices due to “tariffs”.
0 · Reply
DrewskiC99
DrewskiC99 Aug. 1 at 6:09 PM
$ILMN frustrating day after a relatively strong earnings and guidance
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 3:49 PM
RBC Capital updates rating for Illumina ( $ILMN ) to Outperform, target set at 118 → 126.
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 3:27 PM
Canaccord Genuity updates rating for Illumina ( $ILMN ) to Hold, target set at 99 → 105.
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 1:14 PM
Barclays updates rating for Illumina ( $ILMN ) to Underweight, target set at 85 → 90.
0 · Reply
StockAnalyticsAI
StockAnalyticsAI Jul. 31 at 11:30 PM
$ILMN STOCK: Surprise Q2 Beat – Market Shrugs Off Lower Outlook https://youtu.be/F893ch5KE5I?si=vDUV7o2l0PwqYe6i via @YouTube
0 · Reply
arielkhanMD
arielkhanMD Jul. 31 at 8:34 PM
$PACB $ILMN earnings are out raises guidance. Not surprising
1 · Reply
OptionRunners
OptionRunners Jul. 31 at 8:17 PM
$ILMN +3% on earnings
0 · Reply
DonCorleone77
DonCorleone77 Jul. 31 at 7:49 PM
$ILMN Illumina options imply 8.4% move in share price post-earnings
0 · Reply
OptionRunners
OptionRunners Jul. 31 at 6:44 PM
$ILMN Buyer of the January 16th 2026 $130/$150 call spreads 6,469 times for $3.10 ahead of earnings tonight. The December spreads are still in the OI and now trading about $6.80. Repeat flow.
0 · Reply
Estimize
Estimize Jul. 31 at 3:00 PM
$ILMN reports after the close, Estimize Consensus +0.05 EPS and +16.52M Revs compared to WS http://www.estimize.com/ilmn/fq2-2025?utm_conte
0 · Reply
Olddrache
Olddrache Jul. 31 at 2:51 PM
$ILMN Expected Move 7.0%
0 · Reply